Neutralization of nerve growth factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone by Scardigli, R et al.

Neutralization of Nerve Growth Factor Impairs
Proliferation and Differentiation of Adult Neural
























Key Words. Nerve growth factor • Adult neurogenesis • Subventricular zone • Neural stem cells
• Proliferation • Differentiation
ABSTRACT
Adult neurogenesis is a multistep process regulated by several extrinsic factors, including neuro-
trophins. Among them, little is known about the role of nerve growth factor (NGF) in the neuro-
genic niches of the mouse. Here we analyzed the biology of adult neural stem cells (NSCs) from
the subventricular zone (SVZ) of AD11 anti-NGF transgenic mice, in which the expression of the
recombinant antibody aD11 leads to a chronic postnatal neutralization of endogenous NGF. We
showed that AD11-NSCs proliferate 10-fold less, with respect to their control counterparts, and
display a significant impairment in their ability to differentiate into b-tubulin positive neurons. We
found a considerable reduction in the number of SVZ progenitors and neuroblasts also in vivo,
which correlates with a lower number of newborn neurons in the olfactory bulbs of AD11 mice
and a severe deficit in the ability of these mice to discriminate between different odors. We also
demonstrated that, in AD11 mice, the morphology of both SVZ-resident and neurosphere-derived
astrocytes is significantly altered. We were able to reproduce the AD11 phenotype in vitro, by
acutely treating wild type NSCs with the anti-NGF antibody, further demonstrating that both the
proliferation and the differentiation defects are due to the NGF deprivation. Consistently, the pro-
liferative impairment of AD11 progenitors, as well as the atrophic morphology of AD11 astrocytes,
can be partly rescued in vitro and in vivo by exogenous NGF addition. Altogether, our results dem-
onstrate a causal link between NGF signaling and proper proliferation and differentiation of neural
stem cells from the SVZ. STEM CELLS 2014;32:2516–2528
INTRODUCTION
Adult neurogenesis is regulated by physiological
and pathological processes at different levels,
including the proliferation of adult neural stem
cells (NSCs), differentiation and fate determina-
tion of progenitor cells, and the survival, matu-
ration, and integration of newborn neurons [1].
The two neurogenic niches, the subventricular
zone (SVZ) and the subgranular zone of the hip-
pocampal dentate gyrus, have been extensively
characterized by different approaches, such as
in vivo analysis, in vitro assays, and NSCs trans-
plantation assays [1–4], which allowed the dis-
covery of new markers for the identification
and characterization of specific progenitor cell
populations. Despite these extensive studies, it
is still unclear whether neurogenesis is required
for the normal structure and function of the
adult brain, and in particular how it is regulated
both in physiological and pathological condi-
tions. Multiple growth factors control this
important biological process [5]. Among them,
some members of the neurotrophins (NTs) fam-
ily, such as brain-derived nerve factor (BDNF)
and neurotrophin-3 (NT-3), together with their
corresponding receptors (NTRs) (i.e., TrkB, TrkC,
and p75NTR) have been shown to be directly
involved in the biology of adult NSCs [6–8].
While NTs are clearly important for the neuro-
genic process, some controversy remains,
regarding their precise effects. Some suggest
that NTs promote differentiation, while others
suggest that NTs simply promote the survival of
the newborn neurons. Regarding nerve growth
factor (NGF), very little is known about whether
this NT is involved at all in adult neurogenesis.
NGF was shown to enhance the in vitro survival
and differentiation of NSCs isolated from
embryonic forebrain or striatum [9–11], and
NGF receptors p75NTR and TrkA have been dem-
onstrated to be involved in the proliferation of
embryonic stem cells [12]. Some indirect lines
of evidence indicate that NGF and its receptors
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differentiation also in adulthood. For instance, in cerebral ische-
mia animal models, endogenous NGF is upregulated and indu-
ces a neuroprotective effect [13], whereas when intranasally
delivered it enhances striatal neurogenesis [14]. p75NTR is
expressed in mouse and rat adult SVZ progenitors [15], even
though its role in regulating their proliferation and differentia-
tion has been studied only in relationship to their responsive-
ness to BDNF [7, 16]. Altogether, it is not known whether NGF
regulates the physiology of adult NSCs in terms of proliferation,
maintenance, acquisition of a specific phenotype, and proper
differentiation. To address this important issue, we analyzed
adult neurogenesis in the AD11 anti-NGF transgenic mice, in
which the expression of the recombinant anti-NGF antibody
aD11 results in a chronic interference with the activity of
endogenous NGF [17].
MATERIALS AND METHODS
Brain Dissection and Tissue Processing
All experiments with transgenic and control mice were con-
ducted according to national and international laws for labo-
ratory animal welfare and experimentation (EEC council
directive 86/609, OJ L 358, 12 December 1987). For NGF nasal
delivery, recombinant mouse NGF (450 ng/kg) [18] or Phos-
phate-buffered saline (PBS) administration was performed on
anesthetized 6-month-old AD11 mice as described [19]. Prior
to brain dissection, adult mice were anesthetized with about
1 ml of 2,2,2-tribromethanol (Sigma-Aldrich, St. Louis, MO,
http://www.sigmaaldrich.com) and intracardially perfused with
4% paraformaldehyde (PFA), whereas newborns were eutha-
nized by decapitation. The whole brain was therefore
extracted and the fixation continued in 4% PFA overnight at
4C for adult mice and 24 hours for newborns. After cryopro-
tection in 30% sucrose, brains were cryosectioned at 40 lm
of thickness, and slices encompassing the SVZ and the olfac-
tory bulbs (OB) were analyzed by immunohistochemistry.
In Vivo Bromodeoxyuridine Labeling
Bromodeoxyuridine (BrdU) was administered to AD11 and
control adult mice (6-month-old) at 100 mg/kg by daily intra-
peritoneal injections for 5 days. Animals were then sacrificed
either 7 (for SVZ) or 28 days (for OB) after the last injection,
and brains were collected and processed as described before.
For postnatal analysis, AD11 and control newborns (P7, P14,
and P28) received a single dose of BrdU at 100 mg/kg by
intraperitoneal injection and were sacrificed 2 hours after. For
NGF rescue experiments, BrdU was administered for 5 days to
NGF- or PBS-treated animals, during the last week of the
intranasal delivery.
Cell Cultures
NSCs cultures were performed as described [20]. Six-month-
old mice (wild-type or AD11) were anesthetized as described
before and killed by decapitation. Brains were extracted out
of the skull and then located in a brain slicer (Zivic Instru-
ment) in order to obtain coronal slices of 1 mm of thickness.
SVZ regions were dissected out of the brain slices by micro-
dissection performed under a stereomicroscope, and cells
were isolated by enzymatic digestion (1.33 mg/ml trypsin, 0.7
mg/ml hyaluronidase, and 0.2 mg/ml kynurenic acid) (Sigma-
Aldrich) for 30 minutes at 37C and mechanical dissociation
with small-bore Pasteur pipette. Cells were plated at 104 cells
per cm2 cells density and cultured in Dulbecco’s modified
Eagle’s medium (DMEM)/F12 medium supplemented with B27
(Invitrogen, San Diego, CA, http://www.invitrogen.com), epi-
dermal growth factor (EGF), and basic fibroblast growth factor
(bFGF) (20 and 10 ng/ml, respectively; Peprotech, Rocky Hill,
NJ, http://www.peprotech.com) (growing medium) in a
humidified incubator at 37C in 5% CO2 for 3 weeks. Growth
factors were replenished weekly. By the end of 3 weeks, pri-
mary neurospheres (1 mm in diameter) were subcultured
by mechanical dissociation into single cells every 4th day.
Clonal Analysis
Cells isolated from SVZ were cultured under clonal conditions,
ensuring that neurospheres are generated from single cells
and thus serve as an index of the number of in vivo NSCs
[21]. Cells were plated at 5–10 cells per ml (low density) or 50
cells per ml in growing medium. The total number of neuro-
spheres was counted after 3–4 weeks. A minimum of four ani-
mals for each genotype was used in three independent set of
experiments. Anti-NGF mAb aD11 treatment, to acutely
deplete NGF in culture, was performed in freshly isolated wild
type (WT) SVZ cells plated at 10 cells per ml in growing
medium implemented with 100 ng/ml or 1 mg/ml of purified
recombinant aD11 antibody [22]. The antibody was added
every day for 7 days, and then the number and size of neuro-
spheres was measured. Mouse IgG was used as control. The
size of neurospheres was expressed as a volume calculated
after measuring their diameter in phase contrast pictures
(assuming a spherical shape). Brightness and contrast images
of live neurospheres were taken at a Nikon Eclipse Inverted
TE 2000-E microscope, using NIS Elements 3.0 software.
Proliferation Curve and Cell Differentiation
104 viable cells at passage 5 were initially plated in a T24
multiwell in growing medium. After 7 days in vitro, the total
number of viable cells was counted by Trypan blue exclusion,
and all cells were replated under the same conditions at 104
per cm2 cell density. This procedure was repeated for at least
four subculture passages, in order to provide the statistical
mean of the proliferation index of AD11 versus wild-type pro-
genitors. Where indicated, 100 ng/ml of purified recombinant
mouse NGF [18] or BDNF (Peprotech) were added tot the cul-
ture every day. The estimated fold increase (total number of
cells obtained at a given subculture passage/initial number of
seeded cells at the same passage) was then represented using
MatLab software.
To assess for differentiation, neurospheres were dissoci-
ated into single cells and transferred onto matrigel-coated
glass coverslips (12 mm diameter) in differentiating medium
(growth medium without EGF and FGF) at 5 3 104 cells den-
sity. Five days after plating, cultures were fixed in 4% PFA and
processed for immunocytochemistry. For NGF treatment, puri-
fied recombinant mouse NGF [18] was added at 50 ng/ml to
proliferating progenitors every day for 5 days and then to the
differentiating cells every day for 5 days. Where differently
indicated, NGF was added only during differentiation. For
anti-NGF treatment, 100 ng/ml of mAb aD11 was added to
the proliferating progenitors every day for 5 days and then
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cells were induced to differentiate as described, in the pres-
ence of the anti-NGF antibody (every day for 5 days). As con-
trol, mouse IgG was used at the same concentration. Where
differently indicated, mAb aD11 was added either during pro-
liferation or differentiation. For co-cultures experiments, pri-
mary hippocampal neurons were prepared as described [23].
8 3 104 primary neurons were cultured for 1 week on poly-
lysine-coated coverslips (12 mm), and then dissociated neuro-
spheres were added to the neuronal cultures at 5 3 104 cell
density per coverslip in differentiating medium and let differ-
entiate for the following 5 days.
Immunocytochemistry on Brain Sections and
Neurospheres
Immunohistochemistry of SVZ and OB was performed on 40-
mm serial free-floating sections. To improve the efficiency of
BrdU detection, the sections, prior to antibody staining, were
exposed to 2 N HCl for 45 minutes at 37C and then washed
with 0.1 M sodium borate buffer pH 8.5 for 10 minutes (to
allow the denaturation of DNA, necessary to expose the BrdU).
Immunostaining on cell cultures was performed after fixation in
4% PFA for 10 minutes at room temperature. Neurospheres
were plated on matrigel-coated coverslips 2 hours before the
fixation. Upon fixation, sections or cells were permeabilized in
0.3% or 0.1% Triton X-100, respectively, in PBS and then incu-
bated with the antibody of interests, as described in Supporting
Information Materials. The total number of cells in each field
was determined by counterstaining cell nuclei with 4,6-diami-
dine-2-phenylindole dihydrochloride (DAPI; Sigma-Aldrich; 50
mg/ml in PBS for 15 minutes at RT). Immunostained sections
and cells were mounted in Aqua-Poly/Mount (Polysciences,
Inc., Warrington, PA, http://www.polysciences.com) and ana-
lyzed at fluorescent or confocal microscopy, using a Nikon
Eclipse 90i microscope (Nikon) or a TCS SP5 microscope (Leica
Microsystem). Z-stacks images were captured at 1 mm intervals
with a 340 or 360 objectives and a pinhole of 1.0 Airy unit.
Analyses were performed in sequential scanning mode to rule
out cross-bleeding between channels. Fluorescence intensity
quantification was performed with ImageJ software.
Quantification of Cell Numbers
Stereological analysis of the number of cells was performed
on series of 40-mm free-floating coronal sections comprising
the entire SZV or OB, which were analyzed by confocal
microscopy to count cells expressing BrdU throughout the
whole rostro-caudal extent of these structures, counting three
regions per section (top, central, and bottom). To obtain the
average number of SVZ or OB cells per square millimeter, the
number of positive cells for each SVZ and OB section was
multiplied by the total number of sections encompassing the
entire structure. Three animals per group (n 5 3) were ana-
lyzed. Statistical analysis was performed by unpaired Student’s
t test, and all experiments were expressed as mean6 SEM.
To quantify the number of differentiated cells, the number
of Tuj1, glial fibrillary acid protein (GFAP), and O4 immunore-
active cells was counted in at least 10 nonoverlapping fields
in each sample, for a total of >1,000 cells per sample. The
total number of cells in each field was determined by coun-
terstaining cell nuclei with DAPI (Sigma). The average percent-
age of differentiated cells for each samples was then
calculated by dividing the number of Tuj1, GFAP, and O4 posi-
tive cells by the total number of cells for each fields. Data are
the mean 6SEM of three independent cultures (n 5 3), three
independent experiments for each culture. Statistical analysis
was performed by unpaired Student’s t test.
RNA Isolation and Reverse Transcription-Polymerase
Chain Reaction
RNA was isolated from three different AD11 and three differ-
ent WT neurosphere cultures. Briefly, neurospheres were
lysed with Trizol (Invitrogen) and DNAse treated by Qiagen
columns. RNA quantity was determined on a NanoDrop UV-
VIS. Only samples with an absorbance ratio of 1.8,OD260/
OD280,2.0 were processed further. Each sample was then
quality checked for integrity using the Agilent BioAnalyzer
2100 (Agilent G2938C, RNA 6000 nano kit; Agilent, Santa
Clara, CA, http://www.agilent.com): samples with a RNA Integ-
rity Number index lower than 8.0 were discarded. The purified
RNA was used for quantitative reverse transcriptase polymer-
ase chain reaction (qRT-PCR). The first strand cDNA template
was synthesized from 500 ng of total RNA using random pri-
mers and Superscript III reverse transcriptase (Invitrogen). All
reactions were performed with SYBR Green PCR Master Mix
(Bio-Rad, Hercules, CA, http://www.bio-rad.com) and carried
out in the iCycler (Bio-Rad). Primers for quantitative PCR
(QTR-PCR) analysis were designed with the assistance of Uni-
versal Probe Library Software (Roche Applied Science, Basel,
Switzerland, http://www.roche-applied-science.com) and are
described in Supporting Information Materials. All samples
were analyzed in triplicates. Relative change of mRNA amount
was calculated based DCt method, as described [24].
Protein Extraction from Neurospheres and Western
Blotting
Homogeneous suspension of growing neurospheres (about 25
ml of growing medium from a 75 cm2 flask) was lysed in 50 mM
Tris HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.05% Triton plus
proteases inhibitors (Complete Protease Inhibitor Cocktail,
Roche) for 30 minutes in ice. As positive control for activated
caspase-3 detection, cells were treated with 0.5 mM staurospor-
ine (Life Technologies, Grand Island, NY, http://www.lifetech.
com) for 4 hours prior to protein extraction. For phosphorylated
AKT and total AKT detection, cells were starved overnight in
DMEM/F12 and then challenged with 100 ng/ml of purified
recombinant mouse NGF [18] for 30 minutes at 37C, prior to
protein extraction. 50–100 mg of proteins was loaded on SDS-
PAGE 10% and Western blotting was performed as described
[23]. The following primary antibodies were used: rabbit poly-
clonal anti-phosporylated-AKT (Cell Signaling Technology, Bev-
erly, MA, http://www.cellsignal.com, 9271, 1:1,000); rabbit
polyclonal anti-total AKT (Cell Signaling Technology, 9271,
1:1000); rabbit polyclonal anti-activated Caspase-3 (cleaved
caspase-3, Cell Signalling Technology, 9664, 1:1,000); mouse
anti-b-actin (Sigma-Aldrich, A5316, 1:10,000); rabbit polyclonal
anti-Musashi 1 (Msi1, Merck Millipore, Germany, http://www.
millipore.com; AB5977, 1:1,000); mouse anti-Sox2 (Merck Milli-
pore; 6F1.2, 1:500). Secondary horseradish peroxidase-
conjugated anti-mouse or anti-rabbit antibodies and ECL rea-
gent (GE Healthcare, Fairfield, CT, https://www.ge.com/) were
used. Chemiluminescence’s signal was analyzed by Kodak Image
Station 2000R and quantified with the Kodak Molecular Imaging
Software, as a measure of the protein expression level.
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RESULTS
SVZ Progenitors of Adult Anti-NGF AD11 Mice Show a
Proliferative Impairment
In order to study the influence of NGF on adult neurogenesis,
NSC were isolated from the SVZ region of 6-month-old anti-
NGF AD11 mice and grown as neurosphere cultures [25]. In
AD11 mice, the bioactivity of endogenous NGF is neutralized in
the adult brain by the expression of the aD11 anti-NGF anti-
body transgene [17, 26] that selectively binds mature NGF with
a picomolar affinity [18]. Therefore, we first verified whether
resident (in vivo) and SVZ-derived (in vitro) neural progenitors
express the anti-NGF antibody aD11. A double immunostaining
for the human heavy and light chains of the transgenic antibody
was performed on SVZ sections and on bulk neurospheres
obtained from different AD11 and control animals. We could
detect the presence of the recombinant anti-NGF, as shown by
the concomitant immunoreactivity for the two antibody chains
[17], in the SVZ region of AD11 mice (green and red signals in
upper panels, respectively, of Fig. 1A), and not, as expected, of
control mice. Interestingly, the anti-NGF antibody expression
persists in vitro, as demonstrated by the double immunostain-
ing for the two antibody chains also in the AD11 neurospheres
and not in the WT ones (Fig. 1B, upper and lower panels,
respectively). These expression data were further confirmed by
real-time PCR for the heavy and light chains mRNA (Fig. 1C).
The expression of the recombinant mAb aD11 is not expected
to provoke a decreased synthesis of NGF but only a neutraliza-
tion of NGF activity, as a ligand scavenger. Consistently, immu-
nofluorescence for NGF demonstrates that endogenous NGF is
also expressed in the AD11 neurospheres as well as in the WT
counterpart (Fig. 3A, left panel). The overall number of primary
neurospheres obtained by individual SVZ dissections from AD11
mice was significantly lower than from WT animals (Fig. 2A).
Moreover, the majority of AD11 neurospheres were smaller in
size, compared to their control counterpart (50 mm of diame-
ter, 68% in AD11, 21% in WT, Fig. 2B; Supporting Information
Fig. 1A) and expressed lower levels of NSC and progenitor
markers, such as Musashi1 (Msi1) and Sox2, as shown by immu-
nofluorescence and by Western blot analysis on bulk neuro-
spheres (Fig. 2E, 2F). These data could reflect either a
proliferative impairment of the SVZ progenitors and/or reduc-
tion in the number of NSC resident in the SVZ. To address this
point we performed growth curves of progenitors at early pas-
sages. Figure 2C shows that AD11 NSCs proliferated significantly
much less than WT progenitors, with an average 10-fold differ-
ence. This result was confirmed by measuring the expression of
the pan-proliferative marker Ki67 and BrdU incorporation after
short (30 minutes) in vitro BrdU labeling. Double immunostain-
ing for Ki67 and BrdU 48 hours after BrdU pulse showed that
the percentage of proliferating Ki671 and Ki67/BrdU positive
cells was significantly lower in AD11 respect to WT, while the
percentage of quiescent/resting cells (Brdu1/Ki672) increased
(Supporting Information Fig. 1C), suggesting a delayed cell cycle
rate of AD11 cells. Indeed, cell cycle analysis showed an
increase in the G0-G1 phase and a reduction in the G2/M phase
of AD11 respect to WT cells (Supporting Information Fig. 1D,
1E). The proliferative impairment of AD11 progenitors is not
due to an increase in apoptosis, as there are no difference in
the sub-G1 phase of the two populations (not shown) and the
activated form of caspase 3 is detectable at very low levels in
both WT and AD11 neurospheres extracts (Fig. 2D). To further
confirm that this defect is indeed due to NGF neutralization, we
repeated the clonogenic assay with WT progenitors in the pres-
ence of anti-NGF aD11 antibody. As shown in Figure 2G, the
addition of 100 ng/ml or 1 mg/ml of aD11 significantly reduced
the number of primary neurospheres by about 25% and 50%,
respectively, in a dose-dependent manner, with respect to the
control (mouse IgG). This is due to a lower proliferation of anti-
NGF-treated progenitors, as demonstrated by the smaller size
of the corresponding neurospheres (50 mm of diameter, 72%
in AD11, 16% in WT, Fig. 2H; Supporting Information Fig 1B).
Increased Proliferation of AD11 Progenitors in
Response to Exogenous NGF
The proliferative impairment of AD11-SVZ progenitors is likely
to be due to NGF neutralization occurring at an adult stage.
In this view, we asked if these cells still retain the ability to
respond to NGF, and thus if their phenotype could be rescued
by an in vitro exposure to NGF. We first verified by immuno-
fluorescence the expression of NTRs p75 and TrkA in both WT
and AD11 bulk neurospheres. AD11 progenitors express NGF,
as mentioned before, as well as p75 and TrkA receptors, at
levels comparable to those of WT cells (Fig. 3A). We then per-
formed growth curves as described above, in the absence or
presence of 100 ng/ml of NGF or BDNF, a NT widely accepted
to be involved in NSCs proliferation [7, 16]. As shown in Fig-
ure 3B, when NGF was added to the cultures, AD11 progeni-
tors significantly increased their proliferative rate (about two
and six times more in AD9912 and AD9883 clones, respec-
tively), with respect to the untreated (ct) or BDNF-treated
samples, whereas the proliferation of NGF-treated WT cells
was similar to that of untreated and BDNF-treated counter-
parts. Interestingly, the different proliferative response of the
two AD11-derived cultures, after challenge with exogenous
NGF, correlates well with the different level of NGF signaling
activation, in the two cultures, as shown by the increased
amount of the phosphorylated-AKT protein upon NGF stimula-
tion in vitro for 30 minutes (Fig. 3C, 3D). This is not due to an
overall increase of AKT expression, as levels of total AKT pro-
tein remain unchanged between control and treated cells.
Reduced Proliferation and Maturation of SVZ
Progenitors in AD11 Mice In Vivo
The proliferative impairment of AD11 neurospheres observed
in vitro could reflect an intrinsic proliferative feature of the
adult NSCs cells from AD11 mice in vivo, and for this reason
we measured proliferation of AD11 SVZ progenitors in vivo by
BrdU labeling experiments. Adult transgenic and control mice
(6-month-old) received daily BrdU intraperitoneal injections
(100 mg/kg) for 5 days and were sacrificed 1 week from the
first injection for the analysis of BrdU expression in the SVZ.
The control mice showed BrdU positive cells all along the wall
of the ventricle (Fig. 4A). In contrast, AD11 mice present a
marked decrease in the number of cells in proliferation (Fig.
4A and quantification in 4B). As consequence of this prolifera-
tive impairment, the thickness of the lateral ventricle walls
corresponding to SVZ was greatly reduced in 6-month-old
AD11 compared to control mice (Fig. 4A, bottom panels).
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Figure 1. Expression of recombinant aD11 antibody in AD11 subventricular zone (SVZ) region and SVZ-derived neurospheres culture.
(A, B): Immunofluorescence staining for the light (kappa chain, green) and heavy chain (c chain, red) of mAb anti-nerve growth factor
(aD11) showing that the antibody is expressed both in the SVZ region and in SVZ-derived neurospheres cultures of AD11 mice (A and B,
upper panels) but not in those of WT animals (A and B, lower panels). White boxes in each panel represent 363 magnification of the
corresponding dot-lines insets. DAPI staining on nuclei in blue. Scale bars5 50 and 10 lm (enlargements). (C): Real-time polymerase
chain reaction for messenger RNA of heavy chain (VH) and light chain (VK) confirms the expression of aD11 antibody in two independ-
ent AD11 clones (n 5 2). Data are means6 SEM of two independent experiments. *, p< .05, significantly different from WT; Student’s t
test. Abbreviations: DAPI, 4,6-diamidine-2-phenylindole dihydrochloride; VH, heavy chain; VK, light chain; WT, wild type.
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Since aD11 antibody is transiently expressed at embryonic
stage E13 [27], we wanted to exclude that the proliferative
impairment of AD11 progenitors might be a developmental
consequence of a transient early neutralization of NGF. To this
aim, BrdU labeling experiments were performed in AD11 new-
borns, with a single pulse of BrdU (see Materials and Meth-
ods for details), at postnatal stages P7 and p14 when the
transgenic antibody is not expressed yet, or at P28 when
aD11 mRNA starts to be expressed [27, 28]. As shown in Fig-
ure 4C, no significant difference was observed, between AD11
and control newborns, in the number of SVZ-BrdU positive
cells at early postnatal stages (P7 and P14), whereas AD11
animals start showing a decrease in the SVZ progenitor prolif-
eration at P28. These results, together with the data pre-
sented above, demonstrate that the phenotype of AD11
progenitors is due to the NGF neutralization occurring at adult
stage. To further confirm this conclusion, we tried to rescue
this phenotype by the intranasal delivery of NGF in AD11 ani-
mals, which has been reported to rescues recognition mem-
ory deficits in AD11 mice [29]. As shown in Figure 4D, 4E, the
delivery in vivo of NGF to AD11 mice increased the number
of BrdU1 cells, compared to control, PBS-treated animals,
indicating that the proliferative impairment of AD11-SVZ pro-
genitors can be partly rescued by the addition of exogenous
NGF, as we shown in vitro.
The reduced size of the SVZ in AD11 animals correlates
with a lower number of resident progenitors and neuro-
blasts, as demonstrated by the expression levels of the NSC
and progenitor markers Msi1, Sox2, Pax6, and Doublecortin
(Dcx) [30]. Indeed, the immunofluorescence staining per-
formed on coronal brain sections encompassing the SVZ
area showed a significant reduction in the expression level
Figure 2. Subventricular zone (SVZ) progenitors’ proliferation is affected in AD11 mice. (A): Number of primary neurospheres obtained
from WT- and AD11-SVZ progenitors, plated at low (10 cells per ml) or high (50 cells per ml) cellular density. AD11 cells give rise to less
neurospheres in vitro, compared to WT animals. Data are means6 SEM of four individual animals (n 5 4) for each genotype. *, p< .05,
significantly different from WT; Student’s t test. (B): Phase-contrast micrograph of neural stem cells (NSCs) culture showing that AD11
neurospheres (right panel) are smaller in size than WT counterparts (left panel). Scale bar5 25 mm. (C): Proliferative rate of WT and
AD11 neurospheres derived from single animal SVZ, at different passages. AD11 NSCs proliferate significantly less than their WT counter-
parts (n 5 3 for each genotypes). (D): Western blot analysis for cleaved caspase-3 (upper panel) and b-actin (lower panel) in three differ-
ent WT and three AD11 neurosphere cultures (n 5 3), showing no difference in apoptosis between the two genotype populations. ct1:
staurosporine-treated neurosphere extract. (E, F): Progenitor markers are significantly reduced in SVZ-derived neurospheres. (E): Immu-
nofluorescence staining for Msi1 (red) and Sox2 (green) in bulk neurospheres shows that AD11 SVZ (bottom panels) contains less NSCs
than control animals (upper panels). (F): Representative Western-blot analysis for Msi1 and Sox2 proteins in WT and AD11 neurospheres
(left panel) and protein quantification of Msi1 and Sox2 expression (right panel), as mean6 SEM of three independent experiments
(n 5 3).*, p< .05, significantly different from WT, Student’s t test. (G): Clonal analysis of WT progenitors in the presence of anti-nerve
growth factor mAb aD11 antibody. Number of primary neurospheres obtained from WT SVZ progenitors plated at low cellular density
(10 cells per ml) and treated for 1 week with control IgG antibodies (100 ng/ml, light blue bar) or mAb aD11 antibody (100 ng/ml,
orange bar, and 1 mg/ml, red bar). Neurosphere numbers are represented as mean6 SEM of three independent experiments. *, p< .05;
**, p< .01, significantly different from WT, Student’s t test. mAb aD11-treated progenitors give rise to less primary neurospheres, in a
dose-dependent manner, which are also smaller in size respect to the control (H, left and right panels, respectively). Scale bar5 25 mm.
Abbreviations: Msi1, Musashi 1; WT, wild type.
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of these markers in AD11 mice, compared to WT animals
(Fig. 4F).
In order to better identify the possible cellular targets of
the NGF neutralizing action of the antibody, we investigated
the presence of NGF in the SVZ. Since the NGF mRNA is
expressed at low levels in this region (Supporting Information
Table I), we performed our analysis on single cells dissected
out from the SVZ and kept in culture for 24 hours (see Mate-
rials and Methods section). Both nestin1/GFAP1/Sox21 pro-
genitors and some Dcx1 neuroblasts express NGF protein at
levels comparable to those present in b-tubulin1 differenti-
ated neurons (Supporting Information Fig. 2A, 2B), as well as
p75 and TrkA receptors (Supporting Information Fig. 2C).
Thus, it is likely that the action of anti-NGF antibodies is
directed to both progenitors and neuroblasts, and that the
reduction of these populations in the SVZ niche is a direct
consequence of the neutralization of the endogenous NGF,
which might be part of a paracrine or an autocrine loop, also
involving p75 and TrkA receptors.
OB Neurogenesis Is Reduced in AD11 Mice
As OBs neurogenesis is sustained by the NSCs resident in the
SVZ, we measured the number of newborn neurons in the
OBs of AD11 mice, by in vivo BrdU labeling experiments. Four
weeks after a 5-day pulse of BrdU, animals were sacrificed
and the OBs were analyzed for the concomitant expression of
BrdU and the mature neuronal marker NeuN. In accordance
with the neurogenic defects of SVZ progenitors, AD11 mice
display a significant loss of newborn OB neurons, as shown in
Figure 5A and 5C, whereas the total number of NeuN1 cells
Figure 3. Responsiveness to NGF of AD11 progenitors. (A): Immunostaining for NGF, p75, and TrkA (red signal in left, central and right
panels, respectively) in neurospheres derived from WT (upper) and AD11 (bottom) mice. Both WT and AD11 neural stem cells (NSCs)
express NGF and its relative receptors in vitro. White square boxes in each panel represent 363 magnification of the corresponding
dot-lines insets. Scale bars5 50 and 10 mm (enlargements). (B): AD11 progenitors’ proliferation increases in response to exogenous NGF.
Two different AD11 progenitor populations (n 5 2) show a higher fold increase than WT cells when treated with NGF to respect to the
control or BDNF-treated counterparts, as mean6 SEM of three independent experiments. (C, D): Differential pAKT signaling induction by
short pulse of NGF in the same AD11 progenitors populations correlates with their different response to NGF. (C): Western blot analysis
for pAKT, total AKT, and b-actin showing more NGF-induced phosphorylated AKT protein in AD9883 cells than in AD9912. (D): Protein
quantification of pAKT by densitometry of Western blot in panel (B), expressed as pAKT/total AKT ratio, as mean6 SEM of three inde-
pendent experiments. *, p< .05, significantly different from WT, Student’s t test. Abbreviations: BDNF, brain-derived nerve factor; DAPI,
4,6-diamidine-2-phenylindole dihydrochloride; F.I., fold increase; NGF, nerve growth factor; pAKT, phosphorylated AKT; WT, wild type.
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remains equal between the two populations (Fig. 5B), prob-
ably due to the decreased neuronal turnover in the olfactory
system of aged (6–12 months old) mice, as described [31].
We thus investigated if this neurogenic defect in the OB
led to alterations in their odor discrimination ability. To this
aim, we performed a social transmission of food preference
test [32], in a format in which it provides a measure of the
capacity to discriminate odors and not cognitive deficits, since
the interval between the interaction with the demonstrator
and the test for odor preference is too brief to account for
memory deficits [33] (see Materials and Methods section). A
greater percentage of WT observer mice ate more cocoa-
flavored than cumin-flavored food (Fig. 5D). On the contrary,
while the number of sniff interactions was similar between
the two groups (Fig. 5E), AD11 observer mice showed no sig-
nificant difference for preference of the cued food (Fig. 5C),
demonstrating, indeed, an alteration in their olfactory ability
and odor discrimination.
Impaired Differentiation of AD11 NSCs
In addition to the proliferative defect of SVZ progenitors, an
impairment of their differentiation into olfactory interneurons
could also participate in generating the OB phenotype. To
address this point, we tested the differentiating potential of
AD11 neural progenitors in vitro, by measuring the expression
of the neuron-specific class III b-tubulin (TuJ1), upon neuro-
spheres dissociation and differentiation on matrigel-coated
coverslips (see Materials and Methods section). Tuj1 immuno-
staining of differentiated neurospheres showed that AD11
progenitors have an impaired ability to differentiate into neu-
ronal cells (red signal in Fig. 6A) with respect to their WT
counterpart. This was confirmed in different AD11 independ-
ent clones and quantified by counting the percentage TuJ11
cells over the total of DAPI positive nuclei (Supporting Infor-
mation Fig. 3A, see Materials and Methods section for
details). Consistently, AD11 progenitors expressed low levels
of Ngn2 (Supporting Information Fig. 3B), which is known to
be one of the leading proneural gene involved in neurogene-
sis [34]. In the same real-time PCR experiment we also dem-
onstrated that b-tubulin mRNA was downregulated
(Supporting Information Fig. 3C), confirming the expression
data reported in Figure 6A.
In vitro differentiation of AD11 neurospheres revealed
an unbalance in the relative pools of glial subtypes:
Figure 4. In vivo proliferation of subventricular zone (SVZ) progenitors is affected in AD11 mice. (A): Immunostaining for BrdU (red)
incorporated in stem cells and progenitors shows a decrease in cell proliferation in AD11 SVZ (upper right panel), compared to WT
(upper left panel). As consequence, the SVZ of AD11 mice is significantly reduced in thickness, as shown by the cresyl-violet staining on
lateral ventricles from AD11 (bottom right panel) and control (upper left panel). (B): Quantification of BrdU positive cells in 6-month-old
AD11 (magenta) and control (blue) mice. (C): Postnatal analysis of SVZ progenitor proliferation from WT and AD11 newborns at different
ages (P7, P14, and P28) by BrdU in vivo labeling. While the number of BrdU1 cells do not vary significantly between WT and AD11
young newborns (P7 and P14), we observed a decrease of BrdU1 cells in AD11 p28 mice, when the transgenic antibody begins to be
expressed. (D, E): The intranasal delivery of NGF partly rescues AD11 progenitors’ proliferation. (E): In vivo BrdU labeling, performed as
described in the timeline (D), shows an increase of about 20% in the number of BrdU1 SVZ cells after NGF treatment (white bar), com-
pared to control. PBS-treated animals (black bar). (F): Immunofluorescence staining for stem cell (Msi1 and Sox2) and neuroblast
markers (Dcx, Pax6) showing significant reduction in the NSCs compartment in AD11 SVZ. Cell numbers in the SVZ in B, C, and E were
measured as described in Materials and Methods section and are represented as mean6 SEM of the analysis of three animals per
group. **, p< .01; ***, p <.001, significantly different from WT, Student’s t test. Scale bars5 100 mm. Abbreviations: BrdU, bromodeox-
yuridine; Dcx, Doublecortin; Msi, Musashi; NGF, nerve growth factor; PBS, Phospate-buffered saline; WT, wild type.
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GFAP expressing cells were significantly reduced in num-
ber, while O41 oligodendrocytes increased compared to
WT (Fig. 6A; Supporting Information Fig. 3A). Interest-
ingly, GFAP1 cells, differentiated from AD11 progenitors,
lost the bushy-like morphology, typical of astrocytes, and
displayed an elongated shape with few ramifications (Fig.
6A, compare magnifications between right panels), as
also confirmed by the expression pattern of another
astrocytic marker, S100 beta (S100b) (Fig. 6B). This phe-
notype did not depend on the reduced number of differ-
entiated neurons from AD11 neurospheres, as the same
altered GFAP1 astrocytes were obtained in cocultures of
AD11 progenitors with WT primary neurons (Supporting
Information Fig. 4). Moreover, the AD11 astrocytes phe-
notype was present also in vivo, in the SVZ region,
where GFAP1 cells display the same atypical elongated
shape observed in their in vitro counterpart (Fig. 6C).
These data strongly suggest that the glial defect
observed in the differentiated neurospheres cultures is
due to an intrinsic defect of the astrocytes progenitors,
caused by the chronic neutralization of NGF occurring in
vivo in AD11 animals. To test this hypothesis, we verified
whether WT neurospheres, never exposed to anti NGF
antibodies in vivo, were sensitive to acute NGF depriva-
tion, after having been placed in culture. Interestingly,
upon mAb aD11 treatment of WT progenitors, GFAP1
Figure 5. Olfactory bulb neurogenesis is reduced in AD11 mice. (A): BrdU/NeuN double labeling in WT (left panel) and AD11 (right
panel) adult mice revealed less newborn neurons in AD11 olfactory bulbs. Square panels represent 340 magnification of insets in AD11
and WT, respectively. (B, C): Quantification of total NeuN1 cells (B) and of total BrdU1/NeuN1 cells (C) in WT and AD11 OBs. Cell
numbers in OB were measured as described in Materials and Methods section and are represented as mean6 SEM of the analysis of
three animals per group. ***, p< .001, significantly different from WT, Student’s t test. Scale bars5 50 and 100 mm (enlargements). (D,
E): Alterations in olfactory ability and odors discrimination in AD11 mice. Amount of cocoa and cumin flavoured diet, as a percentage of
total intake, eaten by 7-month-old WT and AD11 mice. WT observer mice ate significantly more of the cocoa-flavored diet cued food
than cumin-flavored food (two way RM ANOVA, post hoc analysis Holm-Sidak method, *, p 5 .020), indicating an impairment of AD11
mice in odor discrimination. This defect is not due to a reduced number of sniff interactions between tester and observer mice, as
reported in histogram in (E). Abbreviations: BrdU, bromodeoxyuridine; OB, olfactory bulb; STFP, social transmission of food preference;
WT, wild type.
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astrocytes assume the same elongated shape observed in
the cells differentiated from AD11 neurospheres (Fig. 6D,
upper panels). Conversely, when we added NGF to AD11
progenitors, during proliferation and differentiation, we
could rescue to some extent the glial morphology defects
(Fig. 6D, lower panels), and their number increased to
approximately 50% (not shown). Both treatments (mAb
aD11 on WT cell or NGF on AD11 cells) were effective
only when performed both during proliferation and dif-
ferentiation, whereas had little to none effect when
applied after differentiation has begun (Supporting Infor-
mation Fig. 5), suggesting that functional NGF signaling
is required for astrocytes precursors proliferation and dif-
ferentiation. Indeed, the morphological alteration was
already present in immature AD11 astrocytes, identified
by the concomitant expression of nestin and GFAP [35],
as shown in Figure 7A. Moreover, since AD11 astrocytes
also express late differentiation markers such as GFAP
and S100b (Figs. 6A, 6B, 7A), we believe that their alter-
ation is not due an inability to terminally differentiate,
but most likely to intrinsic cell shaping defects due to
cytoskeleton disassembly, as suggested by the drastic
reduction in both the acetylated and tyrosinated forms
of tubulin (Fig. 7B).
Figure 6. Impaired differentiation of AD11-NSCs. (A): Immunofluorescence staining for neurons (TuJ11, red) and glial cells (GFAP1, green)
shows reduced neuronal and glial differentiation of AD11 neurospheres compared to WT. (A, B): AD11 astrocytes (GFAP1 and S100b1
cells) display an altered elongated shape, compared to WT counterpart. This phenotype is also present in vivo (C), as shown by GFAP immu-
nostaining (green) in AD11 (bottom) and WT (upper) SVZ regions, which reveals the same morphological defect of NSCs-derived astrocytes.
(D): Astrocytes defect depends on NGF neutralization. Differentiated cells stained for GFAP (green) from a WT clone treated with 100 ng/ml
of mAb anti-NGF (mAb aD11, upper panels) 5 days prior to and 5 days during differentiation (see timeline in (E)) show morphological alter-
ation. NGF rescues the astrocytes defects of AD11 progenitors (lower panels). NGF treatment of AD11 progenitors prior and during differen-
tiation (see timeline in (F)), partly rescues their astrocytes atrophy, as revealed by GFAP immunostaining (green). (E, F): Timelines of the
experiments described in (D). Right panels represent a two zoom magnification (363) of the insets in the corresponding left panels. Scale
bars5 75 and 25 mm (enlargements) in (A, B, and D); 50 and 10 mm (enlargements) in (C). Abbreviations: DAPI, 4,6-diamidine-2-phenylin-
dole dihydrochloride; GFAP, glial fibrillary acid protein; NGF, nerve growth factor; WT, wild type.
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DISCUSSION
Here we report for the first time that NGF regulates SVZ neu-
rogenesis, by controlling progenitors’ proliferation, neuronal
differentiation, and OB newborn neurons’ formation. In AD11
mice, NGF neutralization reduces the proliferation of adult
SVZ progenitors and therefore the generation of newborn
olfactory neurons of approximately 50%, which correlates
with an impaired olfaction ability. This phenotype could be
responsible for additional neuronal defects in the olfactory
nervous system, leading to the formation of a disorganized
olfactory epithelium, enlarged in thickness that was previously
observed in adult AD11 mice (S. Capsoni, personal communi-
cation). Interestingly, these animals fail to discriminate
between different odors. However, we cannot exclude that
this olfactory discrimination deficit could also depend on
other neurogenic defects, such as migration failure along the
rostral migratory stream of the AD11 neuroblasts, which
needs further investigations.
The proliferative impairment of AD11-NSCs can be repro-
duced in vitro by acutely treating WT NSCs with the anti-NGF
antibody, whereas the addition of exogenous NGF partly res-
cues AD11 progenitor proliferation, both in vitro and in vivo.
These data demonstrate that this AD11 phenotype depends
on NGF neutralization occurring in the SVZ progenitors. While
NGF expression in the adult SVZ niche has so far been
reported only in rats and monkeys [36–38], here we report
that NGF is expressed in the mouse SVZ region and in SVZ
progenitors at different stages of maturation. This heterogene-
ity of NGF expression in cell subpopulations of the adult SVZ
populations, together with the differential expression of its
receptors TrkA and p75 [39], adds complexity to the possible
role of NGF in regulating adult NSCs and to the interpretation
of the AD11 phenotype. Our data firmly demonstrate that
NGF is required both for progenitors’ proliferation and differ-
entiation, but we can postulate that it might play a role also
in cell fate specification, as demonstrated for the embryonic
precursor cells [10]. A more precise mapping of NGF and
Figure 7. Morphological defects of AD11 astrocytes. (A): Morphological alteration of AD11 astrocytes are present both at immature
and mature stage of differentiation. Co-expression of nestin (red) and GFAP (green) shows that the morphological defect is already pres-
ent at more immature stage (nestin1GFAP) in AD11 astrocytes (lower panels) and persists in more mature, S100b expressing astrocytes
(right lower panel, green), compared to WT astrocytes (upper panels). (B): Immunostaining for acetylated (red) and tyrosinated tubulin
(green) shows the drastic reduction of both forms of tubulin in AD11 GFAP1 (cyano) astrocytes (lower panels), compared to WT (upper
panels). Scale bars5 50 mm (363 magnification, zoom 2) in (A), 10 mm in (B) (363 magnification, zoom 4). Abbreviations: DAPI, 4,6-dia-
midine-2-phenylindole dihydrochloride; GFAP, glial fibrillary acidic protein; WT, wild type.
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NTRs coexpression in the different SVZ populations (i.e., in
NGF-GFP transgenic mice, [40]) would help to achieve a bet-
ter comprehension of the role of this neurotrophic factor in
regulating the homeostasis of adult NSCs during the various
stages of their development. In addition to the reduced prolif-
eration, we also observed a general alteration in the differen-
tiation potential of AD11 NSCs. While the overall percentage
of neurons and astrocytes (btubulin1 and GFAP1) decreased
in AD11 (13% vs. 32% in WT), O41 oligodendrocytes were
more abundant in AD differentiated cultures (2.8 % vs. 0.9%
in WT). This latter result suggests that NGF inhibits oligoden-
drogenesis, similarly to what has been recently reported for
proNGF [41].
We also found a severe morphological alteration of AD11
astrocytes, as shown by the atypical elongated shape of
GFAP1 cells present both in vitro in the differentiating AD11
neurospheres and in vivo in the SVZ. Since AD11 astrocytes
do express markers of mature differentiation, such as GFAP
and S100b, we concluded that their morphological defect is
not due to an inability of AD11 progenitors to terminally dif-
ferentiate into astrocytes, but it is rather due to defects in
cell shaping (already present at early phase of astrocytic mat-
uration), as demonstrated by the drastic reduction of both
the acetylated and tyrosinated forms of tubulin, which sug-
gests a general cytoskeleton disorganization.
The AD11 astrocytes phenotype is reminiscent of similar
morphological alterations reported in the glial compartment
of animal models for Alzheimer’s Disease (AD) [42, 43], that
have been associated either to astrocytes atrophy or to astro-
gliosis observed in different phases of the AD neurodegenera-
tive process [44, 45]. Our results could highlight a role for a
proper NGF signaling in maintaining the homeostasis of the
glial compartment. Interestingly, when we add mAb aD11
NGF-neutralizing antibody to WT differentiating neurospheres,
GFAP1 cells assume the same elongated shape observed in
the AD11 ones, demonstrating that this phenotype is due to
an acute persistent neutralization of NGF activity in vitro, that
mimics the chronic depletion occurring in AD11 mice. Notably,
AD11 animals represent a comprehensive murine model for
AD-like neurodegeneration, as they progressively develop
functional and behavioral impairments that encompass several
features of human AD [26, 46]. Indeed, we also demonstrated
that AD11 mice have an impaired olfaction ability, which is
one of the earliest clinical hallmarks in human AD [47]. Thus,
AD11 mice offer the unique opportunity to study adult neuro-
genesis in a model of neurodegeneration that is NGF-
mediated and thus provide the proper molecular and cellular
environment in which cross-interactions between an altered
NGF signaling and impaired adult neurogenesis can be stud-
ied, in connection with the onset of AD neurodegeneration
phenotype. So far, changes in the expression levels of NGF
and its receptors TrkA and p75 have been reported in differ-
ent AD mouse models of neurodegeneration [48–50] but
never in relationship with possible alterations of adult neuro-
genesis. In this view, our data not only provide a direct dem-
onstration that NGF regulates the proliferation and
differentiation of adult SVZ NSCs but also shed new light on
the possible relationships between altered NGF signaling and
impaired neurogenesis and gliogenesis observed in AD.
CONCLUSION
In summary, this article demonstrates that the chronic deple-
tion of NGF occurring in anti-NGF transgenic AD11 mice leads
to a severe proliferative and differentiative impairment of SVZ
progenitors, both in vivo and in vitro. As a consequence of
these defects, AD11 mice have a lower number of newborn
neurons in the OB, which correlates with a reduced ability in
odor discrimination in these mice. In addition to the neuro-
genic defect, AD11 progenitors fail also to differentiate prop-
erly in glial cells in vitro. Moreover, both SVZ-resident and
neurospheres-derived astrocytes display an atrophic morphol-
ogy. Both this phenotype and the proliferative impairment of
AD11 progenitors can be rescued in vitro by NGF treatment.
Altogether, our data demonstrate for the first time a direct
involvement of NGF in regulating the proliferation of adult
NSCs and their differentiation ability.
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